Pulsed low-dose irradiation of orthotopic glioblastoma multiforme (GBM) in a pre-clinical model: effects on vascularization and tumor control.

[1]  Sean S. Park,et al.  External beam pulsed low dose radiotherapy using volumetric modulated arc therapy: planning and delivery. , 2012, Medical physics.

[2]  Sean S. Park,et al.  MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation. , 2011, International journal of radiation oncology, biology, physics.

[3]  Mitchel S Berger,et al.  An extent of resection threshold for newly diagnosed glioblastomas. , 2011, Journal of neurosurgery.

[4]  A. Friedman,et al.  The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma , 2011, Clinical Cancer Research.

[5]  W. Tomé,et al.  Reirradiation of large-volume recurrent glioma with pulsed reduced-dose-rate radiotherapy. , 2011, International journal of radiation oncology, biology, physics.

[6]  G. Wilson,et al.  The effects of G2-phase enrichment and checkpoint abrogation on low-dose hyper-radiosensitivity. , 2010, International journal of radiation oncology, biology, physics.

[7]  R. Abrams,et al.  Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches , 2010, Journal of oncology.

[8]  Mary Helen Barcellos-Hoff,et al.  Therapeutic targets in malignant glioblastoma microenvironment. , 2009, Seminars in radiation oncology.

[9]  Andrew Bottomley,et al.  Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Stewart,et al.  Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region , 2009, Breast Cancer Research and Treatment.

[11]  D. Gillespie,et al.  Hypoxia‐regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme , 2008, Cancer.

[12]  F. O’Sullivan,et al.  Regional Hypoxia in Glioblastoma Multiforme Quantified with [18F]Fluoromisonidazole Positron Emission Tomography before Radiotherapy: Correlation with Time to Progression and Survival , 2008, Clinical Cancer Research.

[13]  B. Marples,et al.  Low-dose hyper-radiosensitivity: past, present, and future. , 2008, International journal of radiation oncology, biology, physics.

[14]  John Sampson,et al.  Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  W. Tomé,et al.  Pulsed reduced dose-rate radiotherapy: case report : a novel re-treatment strategy in the management of recurrent glioblastoma multiforme. , 2007, Journal of neuro-oncology.

[16]  Martin J. van den Bent,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[17]  Adam P Dicker,et al.  Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  Benedick A Fraass,et al.  Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  T. Lichtor,et al.  In vivo establishment of T98G human glioblastoma. , 1999, Methods and findings in experimental and clinical pharmacology.

[20]  N. Bleehen,et al.  A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. , 1991, British Journal of Cancer.

[21]  G. Laramore,et al.  Radiation Therapy Oncology Group (RTOG) survival data on anaplastic astrocytomas of the brain: does a more aggressive form of treatment adversely impact survival? , 1989, International journal of radiation oncology, biology, physics.